AXQ Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Buy
27,121
+1,056
+4% +$6.46K 0.03% 619
2026
Q1
$199K Buy
26,065
+6,203
+31% +$47.4K 0.03% 752
2025
Q4
$193K Buy
+19,862
New +$169K 0.04% 579
2025
Q2
Sell
-12,191
Closed -$119K 744
2025
Q1
$119K Buy
+12,191
New +$151K 0.05% 434

Other funds holding REPL

AXQ Capital's REPL Position: Q2 2026 in Review

AXQ Capital increased its Replimune Group (REPL) stake by 4.1% in Q2 2026, buying an estimated $6.46K and bringing the position to 27,121 shares worth $300K. The position accounts for 0.03% of the portfolio, ranked #619.

AXQ Capital first reported a position in REPL in Q1 2025 and has held it in 4 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • AXQ Capital held 27,121 shares of Replimune Group worth $300K as of Q2 2026.
  • AXQ Capital bought 1,056 Replimune Group shares in Q2 2026, an estimated $6.46K.
  • Replimune Group made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #619 holding.
  • AXQ Capital first reported a position in Replimune Group in Q1 2025 and has held it in 4 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.